Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
| Trial ID | NCT05142267 |
| Status | Recruiting |
| Condition | Opioid Use Disorder |
| Intervention | Placebo |
This trial addresses the critical intersection of stress, pain management, and opioid misuse risk—a gap in our understanding that has profound implications for prescription practices. By examining how stress modulates opioid effects through endogenous opioid and endocannabinoid pathways, it could inform safer prescribing strategies for patients with chronic pain.
NCT05142267 is a recruiting interventional trial investigating stress-induced changes in opioid medication effects among patients with back pain. The study examines how acute stress exposure influences opioid response and misuse potential, with particular focus on endogenous opioid and endocannabinoid system interactions. Primary endpoints likely include subjective drug effects, physiological responses, and behavioral measures of misuse liability under stressed versus non-stressed conditions.
“If this trial demonstrates that stress significantly amplifies opioid misuse risk through measurable biological pathways, I could incorporate stress assessment and mitigation strategies into my pain management protocols. This mechanistic understanding would strengthen my clinical rationale for recommending cannabis-based alternatives in high-stress patients requiring chronic pain management.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is trial NCT05142267 about?
It is an interventional trial investigating stress-induced changes in how opioid medications affect patients with back pain. The trial listing names opioid use disorder as the condition being studied, and the research centers on whether stress alters the effects of opioid medication in this patient group.
Why does this opioid trial involve the endocannabinoid system?
The trial examines how acute stress exposure influences opioid response and misuse potential, with particular focus on interactions between the endogenous opioid system and the endocannabinoid system. In other words, it looks at whether these two systems in the body are involved in how stress changes the way opioid medications act.
What outcomes will the stress and opioid trial likely measure?
According to the article, the primary endpoints likely include subjective drug effects, physiological responses and behavioral measures of misuse liability. These would be compared under stressed versus non-stressed conditions to see how stress shapes the response to opioid medication.
Has the stress and opioid trial reported any results yet?
Not yet. The trial is listed as recruiting, meaning it is still enrolling participants, so no findings have been reported. Until results are available, it cannot show whether stress changes how opioid medications affect people with back pain.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
